1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2. Research Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Equine
Pharmaceuticals & Supplements Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Pharmaceutical, Supplement)
5.2.2. By Distribution
Channel (Drug Stores, Veterinary Hospitals, Others)
5.2.3.
By Region
5.2.4. By Company (2022)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Distribution Channel
5.3.3. By Region
6.
North America Equine
Pharmaceuticals & Supplements Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
(Pharmaceutical, Supplement)
6.2.2. By Distribution Channel (Drug Stores, Veterinary
Hospitals, Others)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Equine Pharmaceuticals & Supplements Market Outlook
6.3.1.1.
Market Size &
Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share &
Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Distribution
Channel
6.3.2. Canada Equine Pharmaceuticals & Supplements Market Outlook
6.3.2.1.
Market Size &
Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share &
Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Distribution
Channel
6.3.3. Mexico Equine Pharmaceuticals & Supplements
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share &
Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Distribution
Channel
7.
Europe Equine
Pharmaceuticals & Supplements Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
(Pharmaceutical, Supplement)
7.2.2. By Distribution Channel (Drug Stores, Veterinary
Hospitals, Others)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Equine Pharmaceuticals & Supplements Market Outlook
7.3.1.1.
Market Size &
Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share &
Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Distribution Channel
7.3.2. United Kingdom Equine Pharmaceuticals & Supplements Market Outlook
7.3.2.1.
Market Size &
Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share &
Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Distribution
Channel
7.3.3. France Equine Pharmaceuticals & Supplements Market Outlook
7.3.3.1.
Market Size &
Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share &
Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Distribution
Channel
7.3.4. Italy Equine Pharmaceuticals & Supplements Market Outlook
7.3.4.1.
Market Size &
Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share &
Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Distribution
Channel
7.3.5. Spain Equine Pharmaceuticals & Supplements Market Outlook
7.3.5.1.
Market Size &
Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share &
Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Distribution
Channel
8.
Asia-Pacific Equine
Pharmaceuticals & Supplements Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
(Pharmaceutical, Supplement)
8.2.2. By Distribution Channel (Drug Stores, Veterinary
Hospitals, Others)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Equine Pharmaceuticals & Supplements Market Outlook
8.3.1.1.
Market Size &
Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share &
Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Distribution
Channel
8.3.2. Japan Equine Pharmaceuticals & Supplements Market Outlook
8.3.2.1.
Market Size &
Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share &
Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Distribution
Channel
8.3.3. India Equine Pharmaceuticals & Supplements Market Outlook
8.3.3.1.
Market Size &
Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share &
Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Distribution
Channel
8.3.4. Australia Equine Pharmaceuticals & Supplements Market Outlook
8.3.4.1.
Market Size &
Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Distribution
Channel
8.3.5. South Korea Equine Pharmaceuticals & Supplements Market Outlook
8.3.5.1.
Market Size &
Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share &
Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Distribution
Channel
9.
South America Equine
Pharmaceuticals & Supplements Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
(Pharmaceutical, Supplement)
9.2.2. By Distribution Channel (Drug Stores, Veterinary
Hospitals, Others)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Equine Pharmaceuticals & Supplements Market Outlook
9.3.1.1.
Market Size &
Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share &
Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Distribution
Channel
9.3.2. Argentina Equine Pharmaceuticals & Supplements Market Outlook
9.3.2.1.
Market Size &
Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Distribution
Channel
9.3.3. Colombia Equine Pharmaceuticals & Supplements Market Outlook
9.3.3.1.
Market Size &
Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share &
Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Distribution
Channel
10.
Middle East and
Africa Equine Pharmaceuticals & Supplements Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Product
(Pharmaceutical, Supplement)
10.2.2. By Distribution Channel (Drug Stores, Veterinary
Hospitals, Others)
10.2.3. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Equine Pharmaceuticals & Supplements Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Distribution
Channel
10.3.2. Saudi Arabia Equine Pharmaceuticals & Supplements Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Distribution
Channel
10.3.3. UAE Equine Pharmaceuticals & Supplements Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Distribution
Channel
10.3.4. Kuwait Equine Pharmaceuticals & Supplements Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Product
10.3.4.2.2.
By Distribution
Channel
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Products
14. Competitive Landscape
14.1.
Business Overview
14.2.
Product Offerings
14.3.
Recent Developments
14.4.
Financials (As Reported)
14.5.
Key Personnel
14.6.
SWOT Analysis
14.6.1. Zoetis Inc
14.6.2. Boehringer Ingelheim GmbH
14.6.3. Merck & Co Inc
14.6.4. Elanco Animal Health Inc
14.6.5. Bayer AG
14.6.6. Ceva Sante Animale SA
14.6.7. Virbac SA
14.6.8. Vetoquinol SA
14.6.9. Affymetrix Inc
14.6.10.
Celltrion Inc
15. Strategic Recommendations
16.
About Us & Disclaimer